CONMED (CNMD) Competitors $47.62 -1.63 (-3.31%) Closing price 07/18/2025 03:59 PM EasternExtended Trading$47.65 +0.03 (+0.06%) As of 07/18/2025 07:20 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock CNMD vs. MMSI, GKOS, BLCO, IRTC, SLNO, TMDX, INSP, NVST, PRCT, and WRBYShould you be buying CONMED stock or one of its competitors? The main competitors of CONMED include Merit Medical Systems (MMSI), Glaukos (GKOS), Bausch + Lomb (BLCO), iRhythm Technologies (IRTC), Soleno Therapeutics (SLNO), TransMedics Group (TMDX), Inspire Medical Systems (INSP), Envista (NVST), PROCEPT BioRobotics (PRCT), and Warby Parker (WRBY). CONMED vs. Its Competitors Merit Medical Systems Glaukos Bausch + Lomb iRhythm Technologies Soleno Therapeutics TransMedics Group Inspire Medical Systems Envista PROCEPT BioRobotics Warby Parker CONMED (NYSE:CNMD) and Merit Medical Systems (NASDAQ:MMSI) are both medical companies, but which is the better stock? We will compare the two businesses based on the strength of their earnings, analyst recommendations, valuation, media sentiment, institutional ownership, dividends, profitability and risk. Which has better earnings and valuation, CNMD or MMSI? CONMED has higher earnings, but lower revenue than Merit Medical Systems. CONMED is trading at a lower price-to-earnings ratio than Merit Medical Systems, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCONMED$1.31B1.13$132.42M$3.8012.53Merit Medical Systems$1.36B3.62$120.36M$2.0440.70 Which has more volatility & risk, CNMD or MMSI? CONMED has a beta of 1.2, meaning that its stock price is 20% more volatile than the S&P 500. Comparatively, Merit Medical Systems has a beta of 0.65, meaning that its stock price is 35% less volatile than the S&P 500. Do institutionals and insiders hold more shares of CNMD or MMSI? 99.7% of Merit Medical Systems shares are held by institutional investors. 3.1% of CONMED shares are held by insiders. Comparatively, 3.2% of Merit Medical Systems shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth. Is CNMD or MMSI more profitable? CONMED has a net margin of 9.02% compared to Merit Medical Systems' net margin of 8.81%. Merit Medical Systems' return on equity of 15.52% beat CONMED's return on equity.Company Net Margins Return on Equity Return on Assets CONMED9.02% 14.36% 5.86% Merit Medical Systems 8.81%15.52%8.72% Does the media prefer CNMD or MMSI? In the previous week, CONMED and CONMED both had 8 articles in the media. Merit Medical Systems' average media sentiment score of 1.31 beat CONMED's score of 0.88 indicating that Merit Medical Systems is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment CONMED 4 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Merit Medical Systems 5 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do analysts rate CNMD or MMSI? CONMED presently has a consensus price target of $62.20, indicating a potential upside of 30.62%. Merit Medical Systems has a consensus price target of $109.11, indicating a potential upside of 31.43%. Given Merit Medical Systems' stronger consensus rating and higher probable upside, analysts clearly believe Merit Medical Systems is more favorable than CONMED.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score CONMED 0 Sell rating(s) 4 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.20Merit Medical Systems 0 Sell rating(s) 1 Hold rating(s) 8 Buy rating(s) 0 Strong Buy rating(s) 2.89 SummaryMerit Medical Systems beats CONMED on 11 of the 15 factors compared between the two stocks. Get CONMED News Delivered to You Automatically Sign up to receive the latest news and ratings for CNMD and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding CNMD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CNMD vs. The Competition Export to ExcelMetricCONMEDMED/DENTAL IndustryMedical SectorNYSE ExchangeMarket Cap$1.52B$14.64B$5.56B$20.82BDividend Yield1.62%1.45%3.75%3.65%P/E Ratio12.5318.0228.2227.58Price / Sales1.132.11436.6058.71Price / Cash7.3316.9936.1622.29Price / Book1.533.718.114.66Net Income$132.42M$430.42M$3.25B$995.72M7 Day Performance-7.00%-1.89%1.64%-0.30%1 Month Performance-8.45%-0.21%7.28%4.90%1 Year Performance-32.97%13.50%33.14%11.14% CONMED Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CNMDCONMED4.7877 of 5 stars$47.62-3.3%$62.20+30.6%-33.5%$1.52B$1.31B12.533,900News CoverageMMSIMerit Medical Systems4.6225 of 5 stars$93.450.0%$109.11+16.8%-2.8%$5.52B$1.36B45.817,400Positive NewsAnalyst ForecastGKOSGlaukos4.452 of 5 stars$104.43+0.6%$134.67+29.0%-17.6%$5.97B$404.52M-44.06780Positive NewsBLCOBausch + Lomb3.0819 of 5 stars$13.67-1.5%$15.45+13.1%-18.0%$4.83B$4.83B-13.2713,500IRTCiRhythm Technologies1.3213 of 5 stars$138.91+2.2%$138.60-0.2%+38.3%$4.43B$591.84M-44.242,000News CoverageAnalyst ForecastSLNOSoleno Therapeutics4.2775 of 5 stars$82.76+1.5%$108.70+31.3%+88.0%$4.17BN/A-17.9130Analyst RevisionTMDXTransMedics Group2.3182 of 5 stars$116.88+3.9%$127.33+8.9%-23.9%$3.95B$441.54M85.94210Analyst ForecastINSPInspire Medical Systems4.8663 of 5 stars$130.17-0.1%$211.91+62.8%-8.1%$3.84B$802.80M59.981,246Positive NewsAnalyst ForecastNVSTEnvista3.5198 of 5 stars$20.05-0.8%$20.23+0.9%+17.9%$3.40B$2.51B-3.0712,300News CoverageAnalyst RevisionPRCTPROCEPT BioRobotics2.325 of 5 stars$58.17+2.7%$87.50+50.4%-12.6%$3.22B$249.12M-34.22430News CoverageAnalyst ForecastAnalyst RevisionWRBYWarby Parker2.6421 of 5 stars$23.02+3.7%$22.88-0.6%+48.8%$2.41B$795.09M-191.803,780 Related Companies and Tools Related Companies MMSI Competitors GKOS Competitors BLCO Competitors IRTC Competitors SLNO Competitors TMDX Competitors INSP Competitors NVST Competitors PRCT Competitors WRBY Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:CNMD) was last updated on 7/19/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredTurn $1K into $50K with This DeFi GemI've never been more confident about a DeFi opportunity. This isn't about complex trading or risky bets. Th...Crypto 101 Media | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CONMED Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share CONMED With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
